Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Receives Average Rating of “Hold” from Analysts

Acadia Healthcare Company, Inc. (NASDAQ:ACHC) has been assigned an average rating of “Hold” from the sixteen brokerages that are currently covering the company, Marketbeat reports. Two research analysts have rated the stock with a sell recommendation, seven have issued a hold recommendation and seven have assigned a buy recommendation to the company. The average 1 year target price among analysts that have issued ratings on the stock in the last year is $22.1923.

Several brokerages have recently weighed in on ACHC. Guggenheim reduced their price target on Acadia Healthcare from $27.00 to $22.00 and set a “buy” rating for the company in a research report on Monday, February 23rd. TD Cowen raised their target price on Acadia Healthcare from $22.00 to $24.00 and gave the stock a “buy” rating in a research note on Thursday, February 26th. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Acadia Healthcare in a report on Wednesday, January 21st. Raymond James Financial reissued an “outperform” rating and issued a $25.00 price target on shares of Acadia Healthcare in a report on Thursday, February 26th. Finally, UBS Group raised their price objective on shares of Acadia Healthcare from $27.00 to $31.00 and gave the company a “buy” rating in a research report on Friday, April 17th.

Acadia Healthcare Stock Performance

NASDAQ ACHC opened at $28.01 on Thursday. The company’s 50 day moving average is $23.13 and its 200-day moving average is $19.08. The firm has a market cap of $2.58 billion, a P/E ratio of -2.30, a price-to-earnings-growth ratio of 9.27 and a beta of 0.71. Acadia Healthcare has a 12-month low of $11.43 and a 12-month high of $28.48. The company has a quick ratio of 1.55, a current ratio of 1.55 and a debt-to-equity ratio of 1.27.

Acadia Healthcare (NASDAQ:ACHC) last released its quarterly earnings data on Wednesday, February 25th. The company reported $0.07 earnings per share for the quarter, beating analysts’ consensus estimates of $0.03 by $0.04. The business had revenue of $821.46 million during the quarter, compared to analyst estimates of $800.10 million. Acadia Healthcare had a negative net margin of 33.29% and a positive return on equity of 6.53%. Acadia Healthcare’s revenue was up 6.1% compared to the same quarter last year. During the same period in the previous year, the business earned $0.64 EPS. Acadia Healthcare has set its FY 2026 guidance at 1.300-1.550 EPS and its Q1 2026 guidance at 0.250-0.300 EPS. Sell-side analysts predict that Acadia Healthcare will post 1.48 earnings per share for the current year.

Institutional Inflows and Outflows

Several institutional investors have recently made changes to their positions in the company. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. bought a new position in Acadia Healthcare in the 1st quarter worth about $1,600,000. Goldman Sachs Group Inc. increased its holdings in shares of Acadia Healthcare by 21.1% in the 1st quarter. Goldman Sachs Group Inc. now owns 698,225 shares of the company’s stock worth $21,170,000 after buying an additional 121,444 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its stake in Acadia Healthcare by 8.7% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 340,916 shares of the company’s stock valued at $10,337,000 after acquiring an additional 27,207 shares during the last quarter. American Century Companies Inc. raised its position in Acadia Healthcare by 531.5% during the second quarter. American Century Companies Inc. now owns 105,739 shares of the company’s stock valued at $2,399,000 after purchasing an additional 88,995 shares in the last quarter. Finally, Prudential Financial Inc. raised its position in Acadia Healthcare by 21.9% during the second quarter. Prudential Financial Inc. now owns 9,903 shares of the company’s stock valued at $225,000 after purchasing an additional 1,780 shares in the last quarter.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.